CD4 and COVID-19: In contrast, COVID-19 and aTB coinfection, exhibited lower polyfunctional capacity of CD4+ T lymphocytes with less responsive to SARS-CoV-2 specific antigens in comparison with patients with only COVID-19 (15, 16).